["{\n\"step_by_step_thinking\": \"The question asks about the treatment of a specific disease or syndrome using recombinant alpha-iduronidase. The provided documents describe alpha-L-iduronidase as an enzyme required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mucopolysaccharidosis type I (MPS-I) is mentioned as a disease caused by a deficiency of this enzyme. Both Hurler syndrome and MPS-I are related to deficiencies in alpha-L-iduronidase activity, making C: Hurler syndrome the most relevant option.\",\n\"answer_choice\": \"C\"\n}"]